Galapagos NV: business update: http://t.co/6w1jppWE
posted 5 days ago
FlandersBio offers an up-to-date life sciences database containing all the life sciences companies with biotech activity in Flanders, and all FlandersBio members. The guide provides easy and fast access to the local life sciences community.
Life Sciences Database filtered on Therapeutics
You can also perform a new search
Ablynx (Euronext: ABLX) is a biopharmaceutical company engaged in the discovery and development of Nanobodies®, a novel class of therapeutic proteins based on single-domain antibody fragments, for a range of serious and...
ActoGeniX is a biopharmaceutical company focused on the development and commercialization of ActoBiotics™, a novel class of orally available biopharmaceuticals for the targeted treatment of severe diseases with a high...
The objective of the company is to bring its first drug candidate to the clinic in 2 years. AlzProtect will develop its candidates up to clinical phase 2a before licensing them to a Pharma partner for further...
Amakem focuses on the development of locally applied kinase inhibitors using its Localized Drug Action principle for the treatment of diseases with an auto-immune or inflammatory character. Current programs involve Rho...
Amgen Belgium encompasses a wide range of business activities from clinical development to commercial operations. Approximately 3.5 percent of all Amgen clinical patient enrollments each year are in Belgium. Amgen...
Apitope International is a biopharmaceutical company with world leading research and development in the treatment of allergy and autoimmune diseases. Developing novel therapeutic peptide vaccines that represent major...
Arcarios was fouded in 2010 as a merger of the TR-theratpeutcis, a Belgian consortium headed by Tigenix NV and the Therosteon BV. Arcarios is a drug development company dedicated to the discovery and development of...
Arenco develops and commercializes antimalarials but also other (inlicensed) drugs in Africa. Arenco is a small independent pharmaceutical company that has developed a series of β-artemether based anti-malarials. The...
arGEN-X creates novel, antibody-based medicines with the potential to make a meaningful impact on patients’ lives. In so doing, it will provide significant value to all of its stakeholders. Its SIMPLE Antibody™ platform...
Astra Zeneca’s head office, marketing and medical department is located near Brussels. 60 employees work daily with nearly 14,642 patients in 70 clinical studies. Production and packing near Ghent.
Beta-Cell is a privately owned biopharmaceutical company that develops novel cell therapy and other products related to Diabetes. The company is a spin-off from the Vrije Universiteit Brussel - Diabetes Research Center...
Biotech Tools develops new and original proprietary in vitro and in vivo biotech tools to improve diagnosis and improvement of immune response-related diseases. The tools include new proprietary heat shock protein-based...
Brabant Biotech develops new strategies for improved oral and transdermal delivery of peptide based drugs by utilizing recombinant protein methods and outsourced laboratory, clinical and manufacturing activities.
Complix is a biopharmaceutical company engaged in the discovery and development of AlphabodiesT, a revolutionary class of biopharmaceuticals with exceptional properties. AlphabodiesT combine beneficial properties of...
The foundations of the current Dafra Pharma International structure have been laid by the successful development and distribution in Africa of malaria treatments based on artemisinin derivatives. On these stable and...
Eurogentec is a leading provider of reliable and innovative products and services to the Life-Science, Diagnostic and Pharmaceutical community. Employing around 400 people worldwide and with a distribution network in...
Founded as a spin-off of the “Université Libre de Bruxelles”, Euroscreen initially develops and commercializes G Protein-Coupled Receptors (GPCR) reagents. Euroscreen is now developing a pipeline of preclinical...
Fluidda as a company - mission statement: "Engineering for Health"
Application of fluid and structural dynamics in the biomedical field to analyse, design and optimize procedures and medical devices
Formac Pharmaceuticals has developed three proprietary drug delivery technologies allowing pharmaceutical companies to rescue poorly soluble bioactive drug candidates and redirect their development towards value...
Galapagos is a mid-size biotechnology company specialized in the discovery and development of small molecule and antibody therapies with novel modes-of-action. The Company is progressing GLPG0634, as well as one of the...
Genzyme is a global biopharmaceutical company helping patients in more than 100 countries. Genzyme is Sanofi’s global center of excellence in rare diseases and multiple sclerosis (MS). In Geel, Belgium, Genzyme has a...
Based in Gosselies, Belgium, iTeos Therapeutics SA is a private biotechnology company with a focus on developing small-molecule immunomodulators for cancer treatment. Originating from a partnership between the Ludwig...
Janssen Infectious Diseases - Diagnostics is a pharmaceutical research and development company dedicated to the discovery and development of innovative new drugs for HIV/AIDS and other infectious diseases of high unmet...
Our mission:
Kemin Pharma uncovers novel molecules with the potential to cure infections caused by viruses, bacteria, fungi and protozoa and also performs research on alternative approaches to target resistant bacterial strains.
Kingfisher Healthcare (KFH) is an innovative company that develops and produces medical devices by using Bio Electric Stimulation Therapy (B.E.S.T.). This is based on the positive effects of micro current...
MabCure is a biotechnology company whose vision is to change the perception of cancer as a largely incurable disease by early detection of cancer when the disease is still localized and treatable. The key to early...
Molmo Services is a molecular modeling and drug design company that provides a wide range of computational and research services for the chemical and pharmaceutical industry. It offers dedicated software for the most...
Today's Merck is a global healthcare leader, also known as MSD outside the US and Canada. Through our prescription medicines, vaccines, biologic therapies, and consumer care and animal health products, we work with...
MUbio’s business focus is on the development, manufacturing, marketing and sales of research reagents and diagnostic kits. MUbio develops and manufactures high quality antibody reagents for cell biology and biomedical...
Okapi Sciences aims at developing products to treat viral infections in animals, both pet animals and production animals. Viral infections remain a threat to food production and animal health. For several viral...
Omrix biopharmaceuticals aims to develop novel technologies to provide safer and more effective options to patients in areas with substantial unmet medical needs, particularly in the areas of biosurgical and passive...
Oto Therapeutics identifies and develops novel medication for hearing disorders with primary focus on tinnitus.
Oxyrane develops improved therapeutic glycoproteins and antibodies using a glyco-engineered yeast production host and proprietary, purpose-built development tools.
Pfizer discovers, develops, manufactures and markets leading medicines for humans and animals. Their value-added products improve the quality of life of people around the world. Pfizer is a research based pharmaceutical...
The CNS Company PharmaNeuroBoost has two proprietary products in late clinical development stage: the antidepressant (AD) PNB01 in Phase III and the antipsychotic PNB02 in Phase IIa. The PNB01 phase III program is...
You have a promising drug molecule and you are preparing for Pre-clinical or Early Phase Clinical Studies? You are looking for contractors who can characterize, formulate, GMP produce, label and release your clinical...
Promethera® Biosciences is a biopharmaceutical company, spin-off of the Université Catholique de Louvain, that develops innovative treatments based on allogeneic adult stem cell technology. Promethera® Biosciences'...
ReGenesys is a biopharmaceutical company focused on the research and development of stem cell based therapies. ReGenesys is a wholly-owned subsidiary of Athersys, a publicly held biotechnology company located in...
reMYND actively drives the development of disease modifying treatments against Alzheimer’s disease (AD), Parkinson’s disease (PD), and diabetes, either as a Contract Research Organisation (CRO) or through its own drug...
SEPS Pharma applies the combination of carefully designed prodrugs with the appropriate delivery forms creating innovative therapies for patients by expanding the medical application field of existing and...
Shire’s strategic goal is to become the leading specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician. Shire focuses its business on attention deficit hyperactivity disorder,...
Therabel invests in Phase 3 clinical trials of new molecules developed by reliable partners, and in the development of new galenic forms and indications of existing molecules. It has a single up-to-date production site...
ThromboGenics (Euronext Brussels: THR) is a biopharmaceutical company focused on developing and commercializing innovative ophthalmic medicines. The company is also developing two novel antibody therapeutics; these are...
TiGenix NV (NYSE Euronext Brussels: TIG) is a leading European cell therapy company with one product on the market for cartilage repair, and a strong pipeline with clinical stage allogeneic adult stem cell programs for...
